Hypertension

 

Use of Salt Substitute Could Reduce Risk of Stroke, Cardiovascular Events, and Death

August 29, 2021

Data from the Salt Substitute and Stroke Study suggest switching from regular salt to a salt substitute could reduce the risk of stroke by 14% and investigators believe these results can be applied to patient populations across the world.

Cardiology Month in Review: July 2021

July 31, 2021

July's month in review features stories related to EMPEROR-Preserved meeting primary endpoint, a Q&A with Javed Butler, MD, on heart failure prevention, comparing ACEs vs ARBs, and more. Check back around the end of each month for the next Cardiology Month in Review.

ACEs & ARBs Similar in Event Prevention, But ARBs Have Favorable Safety Profile

July 28, 2021

A retrospective cohort study with data from nearly 4 million patients with hypertension from the US, Germany, and South Korea found ACEs and ARBs provide similar efficacy for prevention of cardiovascular events, but ACEs were associated with a greater risk of adverse events.

RADIANCE-HTN TRIO Supports Use of Renal Denervation in Refractory Hypertension

May 18, 2021

Results of RADIANCE-HTN TRIO suggest ultrasound renal denervation could improve blood pressure control in patients with refractory hypertension, suggesting RDN was associated with a mean reduction of 8 mmHg from baseline a 4.5 mmHg improvement over sham procedure.